EMR Technology Solutions 10-K 30 Mar 18 2017 FY Annual report Financial data

Document and Entity Information

Document and Entity Information - USD ($)	12 Months Ended
	Dec. 31, 2017	Mar. 30, 2018	Jun. 30, 2017
Document and Entity Information [Abstract]
Entity Registrant Name	EMR Technology Solutions, Inc.
Entity Central Index Key	1,687,999
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Type	10-K
Document Period End Date	Dec. 31, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	FY
Entity Filer Category	Smaller Reporting Company
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	No
Entity Public Float			$ 0
Entity Common Stock, Shares Outstanding		10,057,254

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Current Assets:
Cash and cash equivalents	$ 8,969	$ 42,186
Accounts receivable, net	66,754	16,579
Total Current Assets	75,723	58,765
Property and equipment, net		818
Other Assets:
Security Deposit	1,450
Software, net	988,838	1,025,169
Customer lists, net	856,898	327,596
Covenant not to compete, net	37,794	3,767
Total other assets	1,884,980	1,356,532
TOTAL ASSETS	1,960,703	1,416,115
Current Liabilities:
Accounts payable	332,760	48,214
Accrued expenses	110,008	34,687
Deferred revenue	51,410
Promissory notes - current portion	175,000
Promissory notes - related party - current portion	125,000
Total Current Liabilities	794,178	82,901
Promissory note - related party - non-current	375,000	500,000
Promissory notes - non-current	375,000	200,000
TOTAL LIABILITIES	1,544,178	782,901
Commitments and Contingencies (See Note 5)
Stockholders' Equity:
Common Stock, 70,000,000 shares authorized, $.001 par value, 10,049,754 and 7,974,252 shares issued and outstanding in 2017 and 2016, respectively	10,050	7,974
Additional paid in capital	3,977,977	2,819,326
Accumulated deficit	(3,571,502)	(2,194,086)
Total stockholders' equity	416,525	633,214
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$ 1,960,703	$ 1,416,115

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Dec. 31, 2017	Dec. 31, 2016
Statement of Financial Position [Abstract]
Common stock, par value	$ 0.001	$ 0.001
Common shares, authorized	70,000,000	70,000,000
Common shares, issued	10,049,754	7,974,252
Common shares, outstanding	10,049,754	7,974,252

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Revenues
Service revenues	$ 123,823	$ 20,488
Contract revenues	511,942	37,705
Total revenues	635,765	58,193
Cost and expenses:
Cost of revenues	145,217	26,267
Selling, general and administrative expense	934,313	2,012,015
Amortization expense	846,510	120,902
Total operating expenses	1,926,040	2,159,184
Loss from operations	(1,290,275)	(2,100,991)
Other Income (Expense)
Loss on conversion of debt		(72,000)
Interest expense	(87,141)	(16,936)
Total other income (expense)	(87,141)	(88,936)
Loss before income taxes	(1,377,416)	(2,189,927)
Provision for income taxes
Net Loss	$ (1,377,416)	$ (2,189,927)
Basic and diluted net loss per common share	$ (0.14)	$ (0.50)
Basic and diluted Weighted Average Number of Common Shares	9,604,882	4,388,597

Consolidated Statement of Chang

Consolidated Statement of Changes in Stockholders' Equity (Deficit) - USD ($)	Total	Common Stock	Additional Paid in Capital	Accumulated Deficit
Balance beginning at Dec. 31, 2015	$ (1,659)	$ 2,500		$ (4,159)
Balance beginning, shares at Dec. 31, 2015		2,500,000
Issuance of Common Stock for cash	355,000	$ 657	354,343
Issuance of Common Stock for cash	500,000	$ 925	499,075
Issuance of Common Stock for cash, shares		925,001
Issuance of Common Stock for acquisition FMS	27,250	$ 50	27,200
Issuance of Common Stock for acquisition FMS, shares		50,000
Issuance of Common Stock for services	550	$ 550
Issuance of Common Stock for services, shares		550,000
Issuance of Common Stock for cash, shares		656,751
Issuance of Common Stock for services	1,620,000	$ 3,000	1,617,000
Issuance of Common Stock for services, shares		3,000,000
Issuance of Common Stock for cash	50,000	$ 92	49,908
Issuance of Common Stock for cash, shares		92,500
Issuance of Common Stock for partial conversion of convertible promissory note	272,000	$ 200	271,800
Issuance of Common Stock for partial conversion of convertible promissory note, shares		200,000
Net Loss	(2,189,927)			(2,189,927)
Balance ending at Dec. 31, 2016	633,214	$ 7,974	2,819,326	(2,194,086)
Balance ending, shares at Dec. 31, 2016		7,974,252
Issuance of Common Stock for cash	300,000	$ 550	299,450
Issuance of Common Stock for cash	750,000	$ 1,388	748,612
Issuance of Common Stock for cash, shares		1,387,501
Issuance of Common Stock for services	27,272	$ 50	27,222
Issuance of Common Stock for services, shares		50,000
Issuance of Common Stock for cash, shares		550,001
Issuance of Common Stock for services	5,455	$ 10	5,445
Issuance of Common Stock for services, shares		10,000
Issuance of Common Stock for cash	3,000	$ 3	2,997
Issuance of Common Stock for cash, shares		3,000
Issuance of Common Stock for conversion of interest	25,000	$ 25	24,975
Issuance of Common Stock for conversion of interest, shares		25,000
Issuance of Common Stock for conversion of principal	50,000	$ 50	49,950
Issuance of Common Stock for conversion of principal, shares		50,000
Net Loss	(1,377,416)		(1,377,416)
Balance ending at Dec. 31, 2017	$ 416,525	$ 10,050	$ 3,977,977	$ (3,571,502)
Balance ending, shares at Dec. 31, 2017		10,049,754

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Cash Flows From Operating Activities:
Net Loss	$ (1,377,416)	$ (2,189,927)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock issued for services	32,727	1,620,550
Amortization	846,511	120,902
Depreciation	818	596
Provision for Bad Debt	31,237
Loss on the conversion of convertible promissory note		72,000
Changes in operating assets and liabilities:
Accounts receivable	220,470	(1,781)
Accounts payable and accrued expenses	239,507	76,505
Deferred revenue	(33,269)
Other assets	(1,450)
Net Cash Used in Operating Activities	(40,865)	(301,155)
Cash Flows From Investing Activities:
Acquisition of entities	(1,045,352)	(560,000)
Net Cash Used in Investing Activities	(1,045,352)	(560,000)
Cash Flows From Financing Activities:
Proceeds from issuance stock	1,053,000	905,000
Repayment of shareholder loan		(1,659)
Net Cash Provided by Financing Activities	1,053,000	903,341
Net Change in Cash and cash equivalents	(33,217)	42,186
Cash and cash equivalents at Beginning of the Period	42,186	0
Cash and cash equivalents at End of the Period	8,969	42,186
Cash paid for interest	68,342
Cash paid for taxes
Non Cash Investing & Financing Activities:
Promissory note obligation incurred upon acquisition	400,000	900,000
Promissory note obligation and accrued interest converted to stock	$ 75,000	$ 200,000

Summary of Significant Accounti

Summary of Significant Accounting Policies and Organization	12 Months Ended
	Dec. 31, 2017
Summary of Significant Accounting Policies and Organization [Abstract]
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION	NOTE 1 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES AND ORGANIZATION (A) Organization The Company is a Nevada corporation formed on November 3, 2015. It was formed as a holding company whose principal activities consists of acquiring electronic medical records and relates services companies. Its fiscal year end is December 31. To date, the Company has financed and acquired four electronic medical records companies. (B) Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include the allocation of purchase price to fair value of assets acquired and valuation of deferred taxes and stock-based compensation. (C) Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At December 31, 2017 and December 31, 2016, the Company had no cash equivalents. ( D Principles of Consolidation The 2017 consolidated financial statements include the operations of EMR Technology Solutions, Inc., its wholly owned subsidiaries First Medical Solutions Corporation (from September 23, 2016), EMRgence, LLC (from September 26, 2016), Empower Technologies, Inc. (from January 1, 2017), and Digital Medical Solutions, Inc. (from March 15, 2017). The 2016 financial statements include the operations of EMR Technology Solutions, Inc., its wholly owned subsidiaries First Medical Solutions Corporation (from September 23, 2016) and EMRgence, LLC (from September 26, 2016). All significant intercompany accounts and transactions have been eliminated in consolidation. (E) Income Taxes We use the asset and liability method to account for income taxes. Under this method, deferred income taxes are determined based on the differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements which will result in taxable or deductible amounts in future years and are measured using the currently enacted tax rates and laws. A valuation allowance is provided to reduce net deferred tax assets to the amount that, based on available evidence, is more likely than not to be realized. The Company follows the provisions of ASC 740-10, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The tax returns for the years ended December 31, 2017, 2016 and 2015 are subject to examination by the Internal Revenue Service. (F) Furniture and Computer Equipment Office Furniture and Computer Equipment are capitalized at cost, net of accumulated depreciation. Depreciation is calculated by using the straight-line method over the estimated useful lives of the assets, which is five to seven years for all categories. Repairs and maintenance are charged to expense as incurred. Expenditures for betterments and renewals are capitalized. The cost of computer equipment and the related accumulated depreciation are removed from the accounts upon retirement or disposal with any resulting gain or loss being recorded in operations. Depreciation/ Amortization Asset Category Period Furniture and fixtures 7 Years Computer equipment 3 Years Computer and equipment and website costs consisted of the following: December 31, December 31, Computer equipment $ 12,758 $ 12,758 Furniture and Fixtures 1,254 1,254 Total 14,012 14,012 Accumulated depreciation (14,012 ) (13,194 ) Balance $ -- $ 818 Depreciation expense for the year ended December 31, 2017 and December 31, 2016 was $818 and $596, respectively. ( G Amortization and Impairment of Long-Lived Assets Amortization and Impairment of long-lived assets are non-cash expenses relating primarily to intangible assets. The Company accounts for long-lived assets in accordance with the provisions of FASB ASC 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Software costs are amortized over three (3) years. Non-compete costs are amortized over three (3) years and Customer Lists are amortized over five (5) years. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. As of December 31, 2017, we have not recorded any impairments. (H) Fair Value Measurements and Fair Value of Financial Instruments The Company adopted FASB ASC Topic 820, Fair Value Measurements. ASC Topic 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The Company did not identify any assets or liabilities that are required to be presented on the balance sheets at fair value in accordance with ASC Topic 820 (F). (I) Business Segments The Company operates in one segment and therefore segment information is not presented. (J) Revenue Recognition The Company recognizes revenue on arrangements in accordance with FASB ASC Topic. 605 “Revenue Recognition”. In all cases, revenue is recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. The Company derives revenue from the sale of hardware and software licenses when the products are installed and all required post implementation services are completed. The Company recognizes revenue from consulting services as the services are performed. (K) Stock-Based Compensation The Company accounts for stock-based instruments issued to employees for services in accordance with ASC Topic 718. ASC Topic 718 requires the Company to recognize in the statement of operations the grant-date fair value of stock options and other equity based compensation issued to employees. The value of the portion of an employee award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC Topic 505-50, “Equity-Based Payments to Non-Employees”. (L) Basic and Diluted Net Loss Per Common Share In accordance with ASC 260-10, “Earnings Per Share”, basic net loss per common share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted loss per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. As of December 31, 2017, and December 31, 2016, the Company has 816,667 and 233,333 shares of common stock issuable upon the conversion of notes payable that were not included in the computation of dilutive loss per share because their inclusion is anti-dilutive for the year ended December 31, 2017 and December 31, 2016. (M) Recent Accounting Pronouncements In April 2016, the FASB issued ASU 2016–10 Revenue from Contract with Customers (Topic 606): identifying Performance Obligations and Licensing “The amendments in this Update do not change the core principle of the guidance in Topic 606. Rather, the amendments in this Update clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. Topic 606 includes implementation guidance on (a) contracts with customers to transfer goods and services in exchange for consideration and (b) determining whether an entity’s promise to grant a license provides a customer with either a right to use the entity’s intellectual property (which is satisfied at a point in time) or a right to access the entity’s intellectual property (which is satisfied over time). The amendments in this Update are intended render more detailed implementation guidance with the expectation to reduce the degree of judgement necessary to comply with Topic 606. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. In May 2017, the Financial Accounting Standards Board (“FASB”) issued an Accounting Standards Update (“ASU”) 2017-09, Compensation- Stock Compensation (Topic718) Clarifying share-based payment modification guidance. The amendments in this update clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date, with early adoption permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Going Concern

Going Concern	12 Months Ended
	Dec. 31, 2017
Going Concern [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities in the normal course of business. The Company sustained a net loss and used cash in operating activities for the year ended December 31, 2017 and December 31, 2016. The Company also has an accumulated deficit at December 31, 2017. These factors raise substantial doubt about the ability of the Company to continue as a going concern for a reasonable period of time. The Company’s continuation as a going concern is dependent upon its ability to generate revenues and its ability to continue receiving investment capital to sustain its current level of operations. Management plans to continue raising additional capital through private placements and is exploring additional avenues for future fund-raising through both public and private sources. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

Acquisitions

Acquisitions	12 Months Ended
	Dec. 31, 2017
Acquisitions [Abstract]
ACQUISITIONS	NOTE 3 – ACQUISITIONS Effective September 23, 2016, EMR entered into a Stock Purchase Agreement (“SPA”) in which EMR purchased all the shares of First Medical Solutions, Inc., a Florida corporation (“FMS”) from Denis Salins, the sole shareholder of FMS. Pursuant to the SPA, EMR acquired FMS whereby FMS became a wholly owned subsidiary of EMR. FMS has developed a proprietary and fully integrated software program for the healthcare industry, targeting the ambulatory care market for electronic medical records. The purchase price was nine hundred seventy-seven thousand two hundred and fifty dollars ($977,250) of which two hundred fifty thousand dollars ($250,000) was paid in cash at close, twenty-seven thousand two hundred and fifty dollars ($27,250) was paid in the form of fifty thousand (50,000) shares of EMR’s common stock, and EMR issued a three (3) year convertible promissory note (“FMS Note”) for seven hundred thousand dollars ($700,000). Effective September 26, 2016, EMR entered into a Purchase Agreement (“PA”) in which EMR purchased all the membership interests of EMRgence, LLC. (“EMRG”), a Florida limited liability corporation, from Susan Turcotte, the sole member of EMRG. Pursuant to the PA, EMR acquired EMRG whereby EMRG became a wholly owned subsidiary of EMR. EMRG has developed a proprietary software program for the healthcare industry, targeting the vascular care market for electronic medical records. The purchase price was five hundred thousand dollars ($500,000) of which three hundred thousand dollars ($300,000) was paid in cash at close and EMR issued a three (3) year convertible promissory note (“EMRG Note”) for two hundred thousand dollars ($200,000). On November 7, 2016, an additional purchase price payment of $11,907 was paid to Susan Turcotte for net revenues earned for the period from September 1, 2016 through September 25, 2016. The acquisition date estimated fair value of the consideration transferred consisted of the following: Tangible assets acquired $ 18,119 Liabilities assumed (6,395 ) Net tangible assets 11,724 Non-compete agreements 4,121 Customer list 346,018 Software 1,127,294 Total purchase price $ 1,489,157 Effective January 1, 2017 (the “Effective Date”), EMR entered into a Purchase Agreement (“Agreement”) by and among Empower Technologies, Inc., a Nevada corporation (“ETI”), and its sole shareholder Dr. John F. Stagl (the “Seller” and together with ETI and the Company, the “Parties”). Pursuant to the Agreement, the Company purchased all of the Capital Stock (as defined in the Agreement) of ETI from the Seller (the “ETI Shares”) in exchange for (i) $500,000, subject to certain post-closing adjustments for working capital and deferred revenue, consisting of (a) $300,000 in cash, and (b) a Convertible Promissory Note (the “Note”) issued in favor of the Seller in the principal amount of $150,000 payable over a 36 month period, with 6% annual interest, convertible into common stock of the Company at a price of $3.00 per share (the “Purchase Price”). On January 16, 2017, in accordance with the terms and conditions of the Agreement, ETI became a wholly owned subsidiary of the Company (the “Closing Date”). The post-closing adjustments referenced above consisted of $4,648 reduction in cash at closing for working capital and a reduction of the convertible promissory note of $50,000 for deferred revenue. The acquisition date estimated fair value of the consideration transferred consisted of the following: Liabilities assumed $ ( 89,911 ) Net liabilities assumed ( 89,911 Non-compete agreements 53,103 Customer list 482,160 Total purchase price $ 535,263 Effective January 1, 2017 (the “Effective Date”), EMR Technologies, Inc., a Nevada corporation (the “Company”) entered into a Purchase Agreement (“Agreement”) by and among Digital Medical Solutions, Inc., a Florida corporation (“DMSI”), and its sole shareholder Dr. Joseph J. Memminger III (the “Seller” and together with DMSI and the Company, the “Parties”). Pursuant to the Agreement, the Company purchased all of the Capital Stock (as defined in the Agreement) of DMSI from the Seller (the “DMSI Shares”) in exchange for (i) $1,000,000, subject to certain post-closing adjustments for working capital and earnings before interest, taxes, depreciation, and amortization, consisting of (a) $750,000 in cash, and (b) a Convertible Promissory Note (the “Note”) issued in favor of the Seller in the principal amount of $250,000 payable over a 36 month period, with 6% annual interest, convertible into common stock of the Company at a price of $3.00 per share (the “Purchase Price”). On March 15, 2017, in accordance with the terms and conditions of the Agreement, DMSI became a wholly owned subsidiary of the Company (the “Closing Date”). The acquisition date estimated fair value of the consideration transferred consisted of the following: Tangible assets acquired $ 300,932 Liabilities assumed (135,219 ) Net tangible assets 165,713 Customer list 384,287 Software 450,000 Total purchase price $ 1,000,000 The agreements resulted in the purchase of 100% of the outstanding shares of FMS, EMRG, ETI, and DMSI. As of December 31, 2017, the Company has recorded an estimated fair value of the intangible assets of FMS, EMRG, ETI, and DMSI based on a preliminary purchase price allocation prepared by management. As a result, during the preliminary purchase price allocation period, which may be up to one year from the business combination date, we may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. After the preliminary purchase price allocation period, we record adjustments to assets acquired or liabilities assumed subsequent to the purchase price allocation period in our operating results in the period in which the adjustments were determined. Pro-forma Financial Information The following unaudited pro-forma information presents the combined results of operations for the periods as if the acquisition of FMS, EMRG, ETI, and DMSI had been completed on January 1, 2017 and 2016. For the Year Ended For the Year Revenue $ 808,563 $ 828,468 Total expenses 2,018,823 2,812,833 Net loss $ (1,210,260 ) $ (1,984,365 ) Net loss per common share, basic and diluted $ (0.12 ) $ (0.27 )

Promissory Notes

Promissory Notes	12 Months Ended
	Dec. 31, 2017
Promissory Notes [Abstract]
PROMISSORY NOTES	NOTE 4 – PROMISSORY NOTES The $700,000 FMS Note has an interest rate of ten percent (10%) per annum for a period of two (2) years and fully amortizes during the third (3rd) year. The note is secured by an escrowed copy of the software source code. The note can be converted at any time, at the option of the holder, into shares of the Company’s stock at a conversion price of $1.00 per share. On October 31, 2016, the holder of the FMS Note converted $200,000 of the note for 200,000 shares of common stock. The Company has recorded loss on conversion of debt of $72,000. On November 15, 2017, the Board of Directors approved an amendment to the FMS Note changing the conversion provision from $3.00 per share to $1.00 per share. On December 31, 2017, the holder of the FMS Note converted $25,000 of interest due for 25,000 shares of common stock. The Company issued a three (3) year convertible promissory note (the “EMRG Note”) for two hundred thousand dollars ($200,000). The EMRG Note has an interest rate of eight percent (8%) per annum for a period of one (1) years and fully amortizes during the next two (2) years. The note is secured with a pledge of forty percent (40%) of the membership interests acquired. The note can be converted at any time, at the option of the holder, into shares of the Company’s stock at a conversion price of $3 per share. On December 29, 2017, the EMRG Note was amended to change the beginning amortization period from December 31, 2017 to March 31, 2018 for $50,000 and 7 equal quarterly installments of $25,000 each thereafter and the interest rate was increased from 6% to 8% annually. The Company issued a three (3) year unsecured convertible promissory note (the “ETI Note”) for one hundred fifty thousand dollars ($150,000). The ETI Note has an interest rate of six percent (6%) per annum for a period of two (2) years and fully amortizes during the third (3rd) year. The note can be converted at any time, at the option of the holder, into shares of the Company’s stock at a conversion price of $3 per share. The Company issued a three (3) year unsecured convertible promissory note (the “DMSI Note”) for two hundred fifty thousand dollars ($250,000). The DMSI Note has an interest rate of six percent (6%) per annum for a period of one (1) year and fully amortizes during the next two (2) years. The note can be converted at any time, at the option of the holder, into shares of the Company’s stock at a conversion price of $1.00 per share. On December 20, 2017, the Agreement was amended to remove the purchase price adjustment for EBITDA. On December 20, 2017, the Note was amended to change the interest only period from one year to two years, changing the beginning of principal payments from December 31, 2017 to December 31, 2018 and to increase the annual interest rate from 6% to 8% commencing January 1, 2018. On December 22, 2017, the Board of Directors approved an amendment to the Note changing the conversion provision from $3.00 per share to $1.00 per share. On December 29, 2017, the Board of Directors approved the request by the holder of the DMSI Note to convert $50,000 principal of the DMSI Note into 50,000 shares of the Company’s common stock. Maturities of Long-Term Obligations for 2018 and Beyond The minimum annual principal payments of notes payable at December 31, 2017 were: 2018 $ 300,000 2019 750,000 Total minimum principal payments $ 1,050,000

Commitments and Contingencies

Commitments and Contingencies	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies [Abstract]
COMMITMENTS AND CONTINGENCIES	NOTE 5 – COMMITMENTS AND CONTINGENCIES On January 15, 2017, the Company entered into a two-year lease for office space, effective January 15, 2017 for a monthly rent of $1,143 per month. The minimum annual lease payments at December 31, 2017 were $13,704. The lease expires January 31, 2019. Rent expense for the year ended December 31, 2017 and December 31, 2016 was $12,562 and $414 respectively. The minimum annual lease payments for 2018 and beyond are: 2018 $ 13,716 2019 1,143 Total minimum lease payments $ 14,859

Stockholders' Equity

Stockholders' Equity	12 Months Ended
	Dec. 31, 2017
Stockholders' Equity [Abstract]
STOCKHOLDERS' EQUITY	NOTE 6 – STOCKHOLDERS’ EQUITY (A) - Stock issued for cash Effective August 23, 2016, the Company entered into an Investor Stock Subscription Agreement (“Agreement”) with an entity controlled by our Chief Financial Officer (the “Investor”) to purchase three million seven hundred thousand (3,700,000) shares of the Company’s common stock for two million dollars ($2,000,000) in tranches based on certain milestone events. On August 23, 2016, the investor purchased 656,751 shares of common stock for $355,000. On September 22, 2016, the Investor purchased 925,001 shares of common stock for $500,000 that was used to close two acquisitions. On December 29, 2016, the Investor purchased 92,500 shares of common stock for $50,000 that was used for working capital. On January 13, 2017, the Investor purchased 550,001 shares of common stock for $300,000 that was used to close an acquisition. On March 17, 2017, the Investor purchased 1,387,501 shares of common stock for $750,000 that was used to close an acquisition. The remaining investments are subject to the company reaching certain milestones under the agreement. On October 23, 2017, the Company issued 3,000 shares of common stock to 15 individual investors at $1.00 per share. (B) - Stock issued for Services On January 6, 2016, the Company issued 550,000 shares of stock to eight individuals for services with a fair value of $550. On August 22, 2016, the Company issued 3,000,000 shares of Common Stock for services with a fair value of $1,620,000 based on recent cash sales. On October 5, 2017, two (2) members of the Board of Directors of the Company were each issued 25,000 of the Company’s common stock with a fair value of $27,272, based on recent cash sales, as compensation for services in such capacity. On October 17, 2017, 10,000 shares of the Company’s common stock with a fair value of $5,455, based on recent cash sales, were issued to a non-executive employee of the Company as a bonus for performance. (C) - Stock issued for Acquisitions On September 23, 2016, the Company issued 50,000 shares of common stock as partial consideration of the acquisition of First Medical Solutions, Inc. with a fair value of $27,250 based on recent cash sales prices. ( D ) - Equity Incentive Plan On January 30, 2016, the Board of Directors, with the approval of a majority of the shareholders of the Company, adopted the 2016 Equity Incentive Plan (the “Plan”) which will be administered by a committee appointed by the Board. The Company, under its 2016 Plan, issues options to various officers, directors and consultants. The options may vest immediately or in equal annual installments over a five-year period. All of the options are exercisable at a purchase price determined by the Board of Directors on the date of grant and may have a term of up to 10 years. On December 12, 2017, the Board of Directors approved the issuance of ninety thousand (90,000) options, with immediate vesting on January 1, 2018, to purchase common stock of the Corporation at a value of $0.001 per share for consulting services. The options will expire five (5) years from the date of the grant, which is January 1, 2018. (E ) – Stock Issued for Conversion of Convertible Promissory Note On October 31, 2016, the holder of the FMS Note converted $200,000 of the note for 200,000 shares of common stock. The Company has recorded a loss on conversion of debt of $72,000. On December 31, 2017, the Company issued 50,000 shares of common stock to a note holder for the conversion of $50,000 of note principal at $1.00 per share. On December 31, 2017, the Company issued 25,000 shares of common stock to a related party note holder for two quarterly interest payments at $1.00 per share.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2017
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 7 - RELATED PARTY TRANSACTIONS During 2015, a stockholder loaned the Company $1,659. The amounts were due on demand, interest free and unsecured. During 2016, the loan was paid in full. On September 12, 2016, the Company paid $200,000 in bonuses to the Chief Executive Officer and Chief Financial Officer with whom the Company does not have employment agreements. On October 5, 2017, two (2) members of the Board of Directors of the Company were each issued 25,000 of the Company’s common stock with a fair value of $27,272, based on recent cash sales, as compensation for services in such capacity. On December 31, 2017, the Company issued 25,000 shares of common stock to a related party note holder for two quarterly interest payments at $1.00 per share.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2017
Income Taxes [Abstract]
INCOME TAXES	NOTE 8 – INCOME TAXES 2017 U.S. Tax Reform On December 22, 2017, President Trump signed into law the Tax Cuts and Jobs Act (the “TCJA”) that significantly reforms the Internal Revenue Code of 1986, as amended (the “Internal Revenue Code”). The TCJA, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, effective as of January 1, 2018; limitation of the tax deduction for interest expense; limitation of the deduction for net operating losses to 80% of current year taxable income and elimination of net operating loss carrybacks, in each case, for losses arising in taxable years beginning after December 31, 2017 (though any such tax losses may be carried forward indefinitely); modifying or repealing many business deductions and credits, including reducing the business tax credit for certain clinical testing expenses incurred in the testing of certain drugs for rare diseases or conditions generally referred to as “orphan drugs”; and repeal of the federal Alternative Minimum Tax (“AMT”). The staff of the Securities and Exchange Commission issued Staff Accounting Bulletin No. 118 to address the application of GAAP in situations when a registrant does not have the necessary information available, prepared or analyzed (including computations) in reasonable detail to complete the accounting for certain income tax effects of the TCJA. In connection with the initial analysis of the impact of the TCJA, the Company remeasured its deferred tax assets and liabilities based on the rates at which they are expected to reverse in the future, which is generally 21%. The remeasurement of the Company's deferred tax assets and liabilities was offset by a change in the valuation allowance. The Company is still in the process of analyzing the impact to the Company of the TCJA. Where the Company has been able to make reasonable estimates of the effects related to which its analysis is not yet complete, the Company has recorded provisional amounts. The ultimate impact to the Company’s consolidated financial statements of the TCJA may differ from the provisional amounts due to, among other things, additional analysis, changes in interpretations and assumptions the Company has made, additional regulatory guidance that may be issued, and actions the Company may take as a result of the TCJA. The accounting is expected to be complete when the Company’s 2017 U.S. corporate income tax return is filed in 2018. The Company’s tax expense differs from the “expected” tax expense for Federal income tax purposes, (computed by applying the United States Federal tax rate of 34% to loss before taxes), as follows: The tax effects of the temporary differences between reportable financial statement income (loss) and taxable income (loss) are recognized as deferred tax assets and liabilities. For the Year For the Year Tax expense (benefit) at the statutory rate $ (444,293 ) $ (703,624 ) State income taxes (benefit), net of federal income tax benefit (90,843 ) (120,446 ) Non-deductible expenses 13,104 637,419 Change in tax rate estimates 222,925 -- Change in valuation allowance 299,107 186,651 Total $ — $ — The tax effect of significant components of the Company’s deferred tax assets and liabilities at December 31, 2017 and December 31, 2016, are as follows: For the Year For the Year Deferred tax assets: Net operating loss carryforward $ 247,090 $ 141,780 Amortization and depreciation 231,129 -- Provision for bad debt 8,163 45,495 Total gross deferred tax assets 486,382 187,725 Less: Deferred tax asset valuation allowance (486,382 ) (187,725 ) Total net deferred tax assets $ — $ — In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. Management considers the scheduled reversal of deferred tax liabilities, projected future taxable income and tax planning strategies in making this assessment. Because of the historical earnings history of the Company, the net deferred tax assets for 2017 and 2016 were fully offset by a 100% valuation allowance. The 2017, 2016, and 2015 tax returns remain subject to audit by various Federal and State taxing authorities.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2017
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 9 – SUBSEQUENT EVENTS On December 12, 2017, the Board of Directors approved the issuance of ninety thousand (90,000) options, with immediate vesting on January 1, 2018, to purchase common stock of the Corporation at a value of $0.001 per share for consulting services. The options will expire five (5) years from the date of the grant, which is January 1, 2018. On January 17, 2018, 7,500 shares of the Company’s common stock with a fair value of $4,050 were issued to a non-executive employee of the Company as a bonus for performance. On January 18, 2018, the Company entered into a Revenue Based Factoring Agreement with a third party. Under the agreement, the Company was advanced $56,500, in cash. The interest rate on this advance is 15.6% with a total repayment obligation of $74,919 for 1 year from the date of the advance. The advance was received by the Company on January, 31, 2018.

Summary of Significant Accoun16

Summary of Significant Accounting Policies and Organization (Policies)	12 Months Ended
	Dec. 31, 2017
Summary of Significant Accounting Policies and Organization [Abstract]
Use of Estimates	(B) Use of Estimates In preparing financial statements in conformity with generally accepted accounting principles, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and revenues and expenses during the reported period. Actual results could differ from those estimates. Significant estimates include the allocation of purchase price to fair value of assets acquired and valuation of deferred taxes and stock-based compensation.
Cash and Cash Equivalents	(C) Cash and Cash Equivalents The Company considers all highly liquid temporary cash investments with an original maturity of three months or less to be cash equivalents. At December 31, 2017 and December 31, 2016, the Company had no cash equivalents.
Principles of Consolidation	( D Principles of Consolidation The 2017 consolidated financial statements include the operations of EMR Technology Solutions, Inc., its wholly owned subsidiaries First Medical Solutions Corporation (from September 23, 2016), EMRgence, LLC (from September 26, 2016), Empower Technologies, Inc. (from January 1, 2017), and Digital Medical Solutions, Inc. (from March 15, 2017). The 2016 financial statements include the operations of EMR Technology Solutions, Inc., its wholly owned subsidiaries First Medical Solutions Corporation (from September 23, 2016) and EMRgence, LLC (from September 26, 2016). All significant intercompany accounts and transactions have been eliminated in consolidation.
Income Taxes	(E) Income Taxes We use the asset and liability method to account for income taxes. Under this method, deferred income taxes are determined based on the differences between the tax basis of assets and liabilities and their reported amounts in the consolidated financial statements which will result in taxable or deductible amounts in future years and are measured using the currently enacted tax rates and laws. A valuation allowance is provided to reduce net deferred tax assets to the amount that, based on available evidence, is more likely than not to be realized. The Company follows the provisions of ASC 740-10, Accounting for Uncertain Income Tax Positions. When tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. In accordance with the guidance of ASC 740-10, the benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above should be reflected as a liability for unrecognized tax benefits in the accompanying consolidated balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination. The tax returns for the years ended December 31, 2017, 2016 and 2015 are subject to examination by the Internal Revenue Service.
Furniture and Computer Equipment	(F) Furniture and Computer Equipment Office Furniture and Computer Equipment are capitalized at cost, net of accumulated depreciation. Depreciation is calculated by using the straight-line method over the estimated useful lives of the assets, which is five to seven years for all categories. Repairs and maintenance are charged to expense as incurred. Expenditures for betterments and renewals are capitalized. The cost of computer equipment and the related accumulated depreciation are removed from the accounts upon retirement or disposal with any resulting gain or loss being recorded in operations. Depreciation/ Amortization Asset Category Period Furniture and fixtures 7 Years Computer equipment 3 Years Computer and equipment and website costs consisted of the following: December 31, December 31, Computer equipment $ 12,758 $ 12,758 Furniture and Fixtures 1,254 1,254 Total 14,012 14,012 Accumulated depreciation (14,012 ) (13,194 ) Balance $ -- $ 818 Depreciation expense for the year ended December 31, 2017 and December 31, 2016 was $818 and $596, respectively.
Amortization and Impairment of Long-Lived Assets	( G Amortization and Impairment of Long-Lived Assets Amortization and Impairment of long-lived assets are non-cash expenses relating primarily to intangible assets. The Company accounts for long-lived assets in accordance with the provisions of FASB ASC 360-10, “Accounting for the Impairment or Disposal of Long-Lived Assets”. This statement requires that long-lived assets and certain identifiable intangibles be reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Software costs are amortized over three (3) years. Non-compete costs are amortized over three (3) years and Customer Lists are amortized over five (5) years. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to future undiscounted net cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the assets. As of December 31, 2017, we have not recorded any impairments.
Fair Value Measurements and Fair Value of Financial Instruments	(H) Fair Value Measurements and Fair Value of Financial Instruments The Company adopted FASB ASC Topic 820, Fair Value Measurements. ASC Topic 820 clarifies the definition of fair value, prescribes methods for measuring fair value, and establishes a fair value hierarchy to classify the inputs used in measuring fair value as follows: Level 1-Inputs are unadjusted quoted prices in active markets for identical assets or liabilities available at the measurement date. Level 2-Inputs are unadjusted quoted prices for similar assets and liabilities in active markets, quoted prices for identical or similar assets and liabilities in markets that are not active, inputs other than quoted prices that are observable, and inputs derived from or corroborated by observable market data. Level 3-Inputs are unobservable inputs which reflect the reporting entity’s own assumptions on what assumptions the market participants would use in pricing the asset or liability based on the best available information. The Company did not identify any assets or liabilities that are required to be presented on the balance sheets at fair value in accordance with ASC Topic 820 (F).
Business Segments	(I) Business Segments The Company operates in one segment and therefore segment information is not presented.
Revenue Recognition	(J) Revenue Recognition The Company recognizes revenue on arrangements in accordance with FASB ASC Topic. 605 “Revenue Recognition”. In all cases, revenue is recognized only when the price is fixed and determinable, persuasive evidence of an arrangement exists, the service is performed and collectability of the resulting receivable is reasonably assured. The Company derives revenue from the sale of hardware and software licenses when the products are installed and all required post implementation services are completed. The Company recognizes revenue from consulting services as the services are performed.
Stock-Based Compensation	(K) Stock-Based Compensation The Company accounts for stock-based instruments issued to employees for services in accordance with ASC Topic 718. ASC Topic 718 requires the Company to recognize in the statement of operations the grant-date fair value of stock options and other equity based compensation issued to employees. The value of the portion of an employee award that is ultimately expected to vest is recognized as an expense over the requisite service periods using the straight-line attribution method. The Company accounts for non-employee share-based awards in accordance with the measurement and recognition criteria of ASC Topic 505-50, “Equity-Based Payments to Non-Employees”.
Basic and Diluted Net Loss Per Common Share	(L) Basic and Diluted Net Loss Per Common Share In accordance with ASC 260-10, “Earnings Per Share”, basic net loss per common share is computed by dividing the net loss for the period by the weighted average number of common shares outstanding during the period. Diluted loss per share are computed using the weighted average number of common and dilutive common stock equivalent shares outstanding during the period. As of December 31, 2017, and December 31, 2016, the Company has 816,667 and 233,333 shares of common stock issuable upon the conversion of notes payable that were not included in the computation of dilutive loss per share because their inclusion is anti-dilutive for the year ended December 31, 2017 and December 31, 2016.
Recent Accounting Pronouncements	(M) Recent Accounting Pronouncements In April 2016, the FASB issued ASU 2016–10 Revenue from Contract with Customers (Topic 606): identifying Performance Obligations and Licensing “The amendments in this Update do not change the core principle of the guidance in Topic 606. Rather, the amendments in this Update clarify the following two aspects of Topic 606: identifying performance obligations and the licensing implementation guidance, while retaining the related principles for those areas. Topic 606 includes implementation guidance on (a) contracts with customers to transfer goods and services in exchange for consideration and (b) determining whether an entity’s promise to grant a license provides a customer with either a right to use the entity’s intellectual property (which is satisfied at a point in time) or a right to access the entity’s intellectual property (which is satisfied over time). The amendments in this Update are intended render more detailed implementation guidance with the expectation to reduce the degree of judgement necessary to comply with Topic 606. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. In May 2017, the Financial Accounting Standards Board (“FASB”) issued an Accounting Standards Update (“ASU”) 2017-09, Compensation- Stock Compensation (Topic718) Clarifying share-based payment modification guidance. The amendments in this update clarify when to account for a change to the terms or conditions of a share-based payment award as a modification. Under the new guidance, modification accounting is required only if the fair value, the vesting conditions, or the classification of the award (as equity or liability) changes as a result of the change in terms or conditions. The guidance is effective for interim and annual periods beginning after December 15, 2017 and should be applied prospectively on or after the effective date, with early adoption permitted. We are currently reviewing the provisions of this ASU to determine if there will be any impact on our results of operations, cash flows or financial condition. Accounting standards-setting organizations frequently issue new or revised accounting rules. We regularly review all new pronouncements to determine their impact, if any, on our financial statements.

Summary of Significant Accoun17

Summary of Significant Accounting Policies and Organization (Tables)	12 Months Ended
	Dec. 31, 2017
Summary of Significant Accounting Policies and Organization [Abstract]
Schedule of useful life of furniture and computer equipment	Depreciation/ Amortization Asset Category Period Furniture and fixtures 7 Years Computer equipment 3 Years
Schedule of computer and equipment and website costs	December 31, December 31, Computer equipment $ 12,758 $ 12,758 Furniture and Fixtures 1,254 1,254 Total 14,012 14,012 Accumulated depreciation (14,012 ) (13,194 ) Balance $ -- $ 818

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Dec. 31, 2017
Acquisitions [Abstract]
Schedule of estimated fair value of consideration transferred on the acquisition date	Tangible assets acquired $ 18,119 Liabilities assumed (6,395 ) Net tangible assets 11,724 Non-compete agreements 4,121 Customer list 346,018 Software 1,127,294 Total purchase price $ 1,489,157 Liabilities assumed $ ( 89,911 ) Net liabilities assumed ( 89,911 Non-compete agreements 53,103 Customer list 482,160 Total purchase price $ 535,263 Tangible assets acquired $ 300,932 Liabilities assumed (135,219 ) Net tangible assets 165,713 Customer list 384,287 Software 450,000 Total purchase price $ 1,000,000
Schedule of pro-forma financial information	For the Year Ended For the Year Revenue $ 808,563 $ 828,468 Total expenses 2,018,823 2,812,833 Net loss $ (1,210,260 ) $ (1,984,365 ) Net loss per common share, basic and diluted $ (0.12 ) $ (0.27 )

Promissory Notes (Tables)

Promissory Notes (Tables)	12 Months Ended
	Dec. 31, 2017
Promissory Notes [Abstract]
Schedule of minimum annual principal payments of notes payable	2018 $ 300,000 2019 750,000 Total minimum principal payments $ 1,050,000

Commitments and Contingencies (

Commitments and Contingencies (Tables)	12 Months Ended
	Dec. 31, 2017
Commitments and Contingencies [Abstract]
Schedule of minimum annual lease payments	2018 $ 13,716 2019 1,143 Total minimum lease payments $ 14,859

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2017
Income Taxes [Abstract]
Schedule of reportable financial statement income (loss) and taxable income (loss)	For the Year For the Year Tax expense (benefit) at the statutory rate $ (444,293 ) $ (703,624 ) State income taxes (benefit), net of federal income tax benefit (90,843 ) (120,446 ) Non-deductible expenses 13,104 637,419 Change in tax rate estimates 222,925 -- Change in valuation allowance 299,107 186,651 Total $ — $ —
Schedule of deferred tax assets and liabilities	For the Year For the Year Deferred tax assets: Net operating loss carryforward $ 247,090 $ 141,780 Amortization and depreciation 231,129 -- Provision for bad debt 8,163 45,495 Total gross deferred tax assets 486,382 187,725 Less: Deferred tax asset valuation allowance (486,382 ) (187,725 ) Total net deferred tax assets $ — $ —

Summary of Significant Accoun22

Summary of Significant Accounting Policies and Organization (Details)	12 Months Ended
	Dec. 31, 2017
Furniture and fixtures [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives years of assets	7 years
Computer equipment [Member]
Property, Plant and Equipment [Line Items]
Estimated useful lives years of assets	3 years

Summary of Significant Accoun23

Summary of Significant Accounting Policies and Organization (Details 1) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Property, Plant and Equipment [Line Items]
Total	$ 14,012	$ 14,012
Accumulated depreciation	(14,012)	(13,194)
Balance		818
Computer equipment [Member]
Property, Plant and Equipment [Line Items]
Total	12,758	12,758
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Total	$ 1,254	$ 1,254

Summary of Significant Accoun24

Summary of Significant Accounting Policies and Organization (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Summary of Significant Accounting Policies and Organization (Textual)
Depreciation expense	$ 818	$ 596
Anti-dilutive securities, shares issuance of conversion of notes payable	816,667	233,333
Non-compete [Member]
Summary of Significant Accounting Policies and Organization (Textual)
Amortization period of intangible assets	3 years
Customer lists [Member]
Summary of Significant Accounting Policies and Organization (Textual)
Amortization period of intangible assets	5 years
Software [Member]
Summary of Significant Accounting Policies and Organization (Textual)
Amortization period of intangible assets	3 years

Acquisitions (Details)

Acquisitions (Details) - USD ($)	Mar. 15, 2017	Jan. 16, 2017	Nov. 07, 2016
EMRgence, LLC. [Member]
Estimated Fair Value of Consideration Transferred
Tangible assets acquired			$ 18,119
Liabilities assumed			(6,395)
Net tangible assets			11,724
Total purchase price			1,489,157
EMRgence, LLC. [Member] | Non-compete Agreements [Member]
Estimated Fair Value of Consideration Transferred
Identifiable assets acquired			4,121
EMRgence, LLC. [Member] | Customer lists [Member]
Estimated Fair Value of Consideration Transferred
Identifiable assets acquired			346,018
EMRgence, LLC. [Member] | Software [Member]
Estimated Fair Value of Consideration Transferred
Identifiable assets acquired			$ 1,127,294
Empower Technologies, Inc. [Member]
Estimated Fair Value of Consideration Transferred
Liabilities assumed		$ (89,911)
Net tangible assets		(89,911)
Total purchase price		535,263
Empower Technologies, Inc. [Member] | Non-compete Agreements [Member]
Estimated Fair Value of Consideration Transferred
Identifiable assets acquired		53,103
Empower Technologies, Inc. [Member] | Customer lists [Member]
Estimated Fair Value of Consideration Transferred
Identifiable assets acquired		$ 482,160
Digital Medical Solutions, Inc. [Member]
Estimated Fair Value of Consideration Transferred
Tangible assets acquired	$ 300,932
Liabilities assumed	(135,219)
Net tangible assets	165,713
Total purchase price	1,000,000
Digital Medical Solutions, Inc. [Member] | Customer lists [Member]
Estimated Fair Value of Consideration Transferred
Identifiable assets acquired	384,287
Digital Medical Solutions, Inc. [Member] | Software [Member]
Estimated Fair Value of Consideration Transferred
Identifiable assets acquired	$ 450,000

Acquisitions (Details 1)

Acquisitions (Details 1) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Acquisitions [Abstract]
Revenue	$ 808,563	$ 828,468
Total expenses	2,018,823	2,812,833
Net loss	$ (1,210,260)	$ (1,984,365)
Net loss per common share, basic and diluted	$ (0.12)	$ (0.27)

Acquisitions (Details Textual)

Acquisitions (Details Textual) - USD ($)	Nov. 07, 2016	Sep. 26, 2016	Sep. 23, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 22, 2017	Jan. 16, 2017
FMS [Member]
Acquisitions (Textual)
Cash paid for acquisition			$ 250,000
Outstanding shares acquired			100.00%
Price per share				$ 1
Interest rate				10.00%
Purchase price of acquisition			$ 977,250
FMS [Member] | Convertible Promissory Note [Member]
Acquisitions (Textual)
Note term			3 years
Notes issued in acquisition			$ 700,000
FMS [Member] | Common Stock [Member]
Acquisitions (Textual)
Value of stock issued in acquisition			$ 27,250
Shares issued in acquisition			50,000
EMRG [Member]
Acquisitions (Textual)
Cash paid for acquisition		$ 300,000
Outstanding shares acquired		100.00%
Note term				3 years
Additional cash payments made for acquisition	$ 11,907
Price per share				$ 3
Interest rate				8.00%
Purchase price of acquisition		$ 500,000
Reduction in cash							$ 4,648
Reduction in convertible promissory note for deferred revenue							$ 50,000
EMRG [Member] | Convertible Promissory Note [Member]
Acquisitions (Textual)
Note term		3 years
Notes issued in acquisition		$ 200,000
ETI [Member] | Effective January 1, 2017 [Member]
Acquisitions (Textual)
Cash paid for acquisition					$ 300,000
Outstanding shares acquired					100.00%
Purchase price of acquisition					$ 500,000
ETI [Member] | Convertible Promissory Note [Member] | Effective January 1, 2017 [Member]
Acquisitions (Textual)
Note term					36 months
Price per share					$ 3
Interest rate					6.00%
Notes issued in acquisition					$ 150,000
DMSI [Member]
Acquisitions (Textual)
Price per share						$ 3
DMSI [Member] | Effective January 1, 2017 [Member]
Acquisitions (Textual)
Cash paid for acquisition					$ 750,000
Outstanding shares acquired					100.00%
Purchase price of acquisition					$ 1,000,000
DMSI [Member] | Convertible Promissory Note [Member] | Effective January 1, 2017 [Member]
Acquisitions (Textual)
Note term					36 months
Price per share					$ 3
Interest rate					6.00%
Notes issued in acquisition					$ 250,000

Promissory Notes (Details)

Promissory Notes (Details)	Dec. 31, 2017USD ($)
Promissory Notes [Abstract]
2,018	$ 300,000
2,019	750,000
Total minimum principal payments	$ 1,050,000

Promissory Notes (Details Textu

Promissory Notes (Details Textual) - USD ($)	Oct. 31, 2016	Dec. 29, 2017	Dec. 20, 2017	Dec. 31, 2017	Dec. 31, 2016	Dec. 22, 2017	Nov. 15, 2017
Promissory Notes (Textual)
Converted shares of common stock				$ 75,000	$ 200,000
Converted shares of common stock, shares				50,000
Loss on conversion of debt					$ (72,000)
FMS [Member]
Promissory Notes (Textual)
Unsecured note				$ 700,000
Interest rate				10.00%
Interest rate, description				An interest rate of ten percent (10%) per annum for a period of two (2) years and fully amortizes during the third (3rd) year.
Debt collateral, description				An escrowed copy of the software source code.
Conversion price				$ 1
FMS [Member] | Maximum [Member]
Promissory Notes (Textual)
Conversion price							$ 3
FMS [Member] | Minimum [Member]
Promissory Notes (Textual)
Conversion price							$ 1
FMS [Member] | Converted stock [Member]
Promissory Notes (Textual)
Converted shares of common stock	$ 200,000			$ 25,000
Converted shares of common stock, shares	200,000			25,000
FMS [Member] | Unsecured convertible promissory note [Member]
Promissory Notes (Textual)
Loss on conversion of debt	$ 72,000
EMRG [Member]
Promissory Notes (Textual)
Note term, issued				3 years
Unsecured note				$ 200,000
Interest rate				8.00%
Interest rate, description				An interest rate of eight percent (8%) per annum for a period of one (1) years and fully amortizes during the next two (2) years.
Debt collateral, description		The EMRG Note was amended to change the beginning amortization period from December 31, 2017 to March 31, 2018 for $50,000 and 7 equal quarterly installments of $25,000 each thereafter and the interest rate was increased from 6% to 8% annually.		Pledge of forty percent (40%) of the membership interests acquired.
Conversion price				$ 3
ETI [Member] | Unsecured convertible promissory note [Member]
Promissory Notes (Textual)
Note term, issued				3 years
Unsecured note				$ 150,000
Interest rate				6.00%
Interest rate, description				An interest rate of six percent (6%) per annum for a period of two (2) years and fully amortizes during the third (3rd) year.
Debt collateral, description				The note can be converted at any time, at the option of the holder, into shares of the Company's stock.
Conversion price				$ 3
DMSI [Member]
Promissory Notes (Textual)
Debt collateral, description			The Note was amended to change the interest only period from one year to two years, changing the beginning of principal payments from December 31, 2017 to December 31, 2018 and to increase the annual interest rate from 6% to 8% commencing January 1, 2018.
Conversion price						$ 3
DMSI [Member] | Maximum [Member]
Promissory Notes (Textual)
Conversion price			$ 3
DMSI [Member] | Minimum [Member]
Promissory Notes (Textual)
Conversion price			$ 1
DMSI [Member] | Unsecured convertible promissory note [Member]
Promissory Notes (Textual)
Note term, issued				3 years
Unsecured note				$ 250,000
Interest rate				6.00%
Interest rate, description				An interest rate of six percent (6%) per annum for a period of one (1) year and fully amortizes during the next two (2) years.
Debt collateral, description				The note can be converted at any time, at the option of the holder, into shares of the Company's stock.
Conversion price				$ 1
Converted shares of common stock		$ 50,000
Converted shares of common stock, shares		50,000

Commitments and Contingencies30

Commitments and Contingencies (Details)	Dec. 31, 2017USD ($)
Commitments and Contingencies [Abstract]
2,018	$ 13,716
2,019	1,143
Total minimum lease payments	$ 14,859

Commitments and Contingencies31

Commitments and Contingencies (Details Textual) - USD ($)	Jan. 15, 2017	Dec. 31, 2017	Dec. 31, 2016
Commitments and Contingencies (Textual)
Rent expense		$ 12,562	$ 414
Monthly rent per month	$ 1,143
Minimum annual lease payments		$ 13,704
Lease expires date		Jan. 31, 2019

Stockholders' Equity (Details)

Stockholders' Equity (Details) - USD ($)	Dec. 12, 2017	Oct. 17, 2017	Oct. 05, 2017	Mar. 17, 2017	Jan. 13, 2017	Oct. 31, 2016	Sep. 23, 2016	Sep. 22, 2016	Aug. 23, 2016	Aug. 22, 2016	Jan. 06, 2016	Oct. 23, 2017	Dec. 29, 2016	Dec. 31, 2017	Dec. 31, 2016
Stockholders' Equity (Textual)
Issuance of common stock for cash														$ 300,000	$ 355,000
Shares price												$ 1		$ 1
Shares, issued												3,000
Number of board of directors			2
Number of individual investors											8	15
Fair value of shares issued for services		$ 5,455	$ 27,272							$ 1,620,000	$ 550			$ 32,727	1,620,550
Issuance of stock for services, shares			25,000							3,000,000	550,000
Common stock issued non-executive employee		10,000
Stock option vesting period	5 years
Debt converted amount														$ 75,000	200,000
Shares issued in debt conversion of common stock														50,000
Loss on conversion of debt															$ (72,000)
Options to purchase common stock	90,000
Chief Financial Officer [Member]
Stockholders' Equity (Textual)
Shares subscribed									3,700,000
Value of stock subscription									$ 2,000,000
Issuance of common stock for cash				$ 750,000	$ 300,000			$ 500,000	$ 355,000				$ 50,000
Issuance of common stock for cash, shares				1,387,501	550,001			925,001	656,751				92,500
FMS [Member] | Common Stock [Member]
Stockholders' Equity (Textual)
Business acquisition, equity interest issued or issuable							$ 27,250
Business acquisition, equity interest issued or issuable, shares							50,000
Conversion of Convertible Promissory Note [Member]
Stockholders' Equity (Textual)
Shares price														$ 1
Debt converted amount						$ 200,000
Shares issued in debt conversion of common stock						200,000								25,000
Loss on conversion of debt						$ 72,000
2016 Equity Incentive Plan [Member]
Stockholders' Equity (Textual)
Shares price	$ 0.001
Stock option term															10 years
Stock option vesting period															5 years
The options expire term	5 years

Related Party Transactions (Det

Related Party Transactions (Details) - USD ($)	Oct. 17, 2017	Oct. 05, 2017	Oct. 31, 2016	Sep. 12, 2016	Aug. 22, 2016	Jan. 06, 2016	Dec. 31, 2017	Dec. 31, 2016	Dec. 31, 2015	Oct. 23, 2017
Related Party Transactions (Textual)
Fair value of shares issued for services	$ 5,455	$ 27,272			$ 1,620,000	$ 550	$ 32,727	$ 1,620,550
Issuance of stock for services, shares		25,000			3,000,000	550,000
Loans received from stockholder								$ (1,659)
Shares price							$ 1			$ 1
Common stock issue to a related party note holder							50,000
Number of board of directors		2
Convertible Promissory Note [Member]
Related Party Transactions (Textual)
Shares price							$ 1
Common stock issue to a related party note holder			200,000				25,000
Chief Financial Officer [Member]
Related Party Transactions (Textual)
Bonus paid				$ 200,000
Stockholder [Member]
Related Party Transactions (Textual)
Loans received from stockholder									$ 1,659
Chief Executive Officer [Member]
Related Party Transactions (Textual)
Bonus paid				$ 200,000

Income Taxes (Details)

Income Taxes (Details) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Taxes [Abstract]
Tax expense (benefit) at the statutory rate	$ (444,293)	$ (703,624)
State income taxes (benefit), net of federal income tax benefit	(90,843)	(120,446)
Non-deductible expenses	13,104	637,419
Change in tax rate estimates	222,925
Change in valuation allowance	299,107	186,651
Total

Income Taxes (Details 1)

Income Taxes (Details 1) - USD ($)	Dec. 31, 2017	Dec. 31, 2016
Deferred tax assets:
Net operating loss carryforward	$ 247,090	$ 141,780
Amortization and depreciation	231,129
Provision for bad debt	8,163	45,495
Total gross deferred tax assets	486,382	187,725
Less: Deferred tax asset valuation allowance	(486,382)	(187,725)
Total net deferred tax assets

Income Taxes (Details Textual)

Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Dec. 31, 2017	Dec. 31, 2016
Income Taxes (Textual)
Federal tax rate	34.00%
Loss carryforwards
Percentage of valuation allowance	100.00%	100.00%
U.S. tax reform, description	The TCJA, among other things, contains significant changes to corporate taxation, including reduction of the corporate tax rate from a top marginal rate of 35% to a flat rate of 21%, effective as of January 1, 2018; limitation of the tax deduction for interest expense; limitation of the deduction for net operating losses to 80% of current year taxable income and elimination of net operating loss carrybacks, in each case, for losses arising in taxable years beginning after December 31, 2017 (though any such tax losses may be carried forward indefinitely); modifying or repealing many business deductions and credits, including reducing the business tax credit for certain clinical testing expenses incurred in the testing of certain drugs for rare diseases or conditions generally referred to as "orphan drugs"; and repeal of the federal Alternative Minimum Tax ("AMT").

Subsequent Events (Details)

Subsequent Events (Details) - USD ($)	Jan. 18, 2018	Dec. 12, 2017	Oct. 17, 2017	Jan. 17, 2018
Subsequent Events (Textual)
Common stock issued non-executive employee			10,000
Options to purchase common stock		(90,000)
Vesting description		Options, with immediate vesting on January 1, 2018, to purchase common stock of the Corporation at a value of $0.001 per share for consulting services.
Purchase of stock per share price		$ 0.001
Stock option vesting period		5 years
Subsequent Events [Member]
Subsequent Events (Textual)
Common stock issued non-executive employee				7,500
Fair value issued to a non-executive employee				$ 4,050
Advanced cash	$ 56,500
Interest rate	15.60%
Total repayment obligation	$ 74,919
Debt instrument, description	Under the agreement, the Company was advanced $56,500, in cash. The interest rate on this advance is 15.6% with a total repayment obligation of $74,919 for 1 year from the date of the advance. The advance was received by the Company on January, 31, 2018.